These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3319461)

  • 1. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc-labeled 5-ASA suppositories.
    Williams CN; Haber G; Aquino JA
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):71S-75S. PubMed ID: 3319461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
    D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G
    Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis.
    van Hogezand RA; van Hees PA; van Gorp JP; van Lier HJ; Bakker JH; Wesseling P; van Haelst UJ; van Tongeren JH
    Aliment Pharmacol Ther; 1988 Feb; 2(1):33-40. PubMed ID: 2979230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada.
    Sutherland LR; Martin F
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):64S-66S. PubMed ID: 3319459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.
    Campieri M; De Franchis R; Bianchi Porro G; Ranzi T; Brunetti G; Barbara L
    Scand J Gastroenterol; 1990 Jul; 25(7):663-8. PubMed ID: 2204103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
    Freund U; Schölmerich J; Siems H; Kluge F; Schäfer HE; Wannenmacher M
    Strahlenther Onkol; 1987 Oct; 163(10):678-80. PubMed ID: 3313776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
    van Hees PA; Bakker JH; van Tongeren JH
    Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.
    Lucidarme D; Marteau P; Foucault M; Vautrin B; Filoche B
    Aliment Pharmacol Ther; 1997 Apr; 11(2):335-40. PubMed ID: 9146772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.
    Lamet M
    Dig Dis Sci; 2011 Feb; 56(2):513-22. PubMed ID: 20676771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of rectal formulations: suppositories.
    Williams CN
    Scand J Gastroenterol Suppl; 1990; 172():60-2. PubMed ID: 2191425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis?
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L
    J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Brunetti G; Miglioli M; Barbara L
    Int J Colorectal Dis; 1990 May; 5(2):79-81. PubMed ID: 2193075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: a multicenter randomized study.
    Lamet M; Ptak T; Dallaire C; Shah U; Grace M; Spenard J; de Montigny D;
    Inflamm Bowel Dis; 2005 Jul; 11(7):625-30. PubMed ID: 15973115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.
    d'Albasio G; Paoluzi P; Campieri M; Bianchi Porro G; Pera A; Prantera C; Sturniolo GC; Miglioli M
    Am J Gastroenterol; 1998 May; 93(5):799-803. PubMed ID: 9625131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
    Gionchetti P; Rizzello F; Venturi A; Ferretti M; Brignola C; Miglioli M; Campieri M
    Dis Colon Rectum; 1998 Jan; 41(1):93-7. PubMed ID: 9510317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group.
    Marteau P; Florent C
    Am J Gastroenterol; 2000 Jan; 95(1):166-70. PubMed ID: 10638577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
    Bosworth BP; Sandborn WJ; Rubin DT; Harper JR
    Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.
    Lie MRKL; Kreijne JE; Dijkstra G; Löwenberg M; van Assche G; West RL; van Noord D; van der Meulen-de Jong AE; Oldenburg B; Zaal RJ; Hansen BE; de Vries AC; Janneke van der Woude C;
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1777-1784.e2. PubMed ID: 31610337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
    Gionchetti P; Rizzello F; Venturi A; Brignola C; Ferretti M; Peruzzo S; Campieri M
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1053-7. PubMed ID: 9663829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.